Log In
BCIQ
Print this Print this
 

IONIS-GCGRRx (formerly ISIS-GCGRRx)

Also known as: formerly ISIS-GCGR

  Manage Alerts
Collapse Summary General Information
Company Ionis Pharmaceuticals Inc.
DescriptionAntisense inhibitor targeting glucagon receptor (GCGR)
Molecular Target Glucagon receptor (GCGR)
Mechanism of ActionAntisense therapy
Therapeutic ModalityNucleic acid: Linear RNA: Antisense
Latest Stage of DevelopmentPhase II
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today